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Abstract 
Introduction and aims 
The aim of this study was to describe and analyse selected pharmacotherapy risks in everyday 
clinical practice. The paper focused on the guidance of the secondary prevention after 
myocardial infarction (MI), on opinions, attitudes and experience of general practitioners with 
generic substitution and on self-medication of the elderly in the Czech Republic. 
Randomized controlled trials offer us basic information about effectiveness and safety of 
drugs. Unfortunately these trials are not able to reveal all drug risks that can even vitally 
change the therapeutic value of the drug even though there is a selection of patients who enter 
the study and there are strict conditions for carrying out of these trials. Drug-related problems 
(DRPs) appear in clinical practice relatively a lot. Non-prescription of drugs that 
fundamentally decrease mortality, inappropriate drug prescription from the point of view of 
age or comorbidities, treatment duplicity or non-compliance risk belong among these DRPs. 
The target of this study was to describe selected pharmacotherapy risks (particular DRPs) that 
can appear in everyday clinical practice. We focused on the description of MI secondary 
prevention with the help of EBM, on opinions, attitudes and experience of general 
practitioners with generic drugs and generic substitution and on the self-medication of the 
elderly with the focus on the knowledge and experience with the medicine containing 
ibuprofen. 
1. Prescription of EBM to patients in MI secondary prevention by general 
practitioners in the Czech Republic 
Aim 
The aim was to carry out the analysis of prescription of EBM in patients in MI secondary 
prevention in the Czech Republic. 
Methods 
Two studies with similar methodology were carried out. Input data from Atlet project (that 
monitored the medically preventive care of general practitioners in patients with the high risk 
of cardiovascular diseases) were used in the first study. All patients after myocardial 
infarction in anamnesis and with filled complete medication were relegated. Data from 
electronic documentation of general practitioners (consultants and members of SVL ČLS JEP 
panel) were used in the second study where all patients in MI secondary prevention were 
included. Gender, patients’ age and the prescription of EMB (beta-blockers, ACEI/ARB, 
statins, antiplatelet drugs) were observed in both studies. The compensation of cardiovascular 
diseases risk factors was also observed in the first study and the time period since myocardial 
infarction was observed in the second one. Statistical analysis of data was carried out in 
SPSS
®
 16.0 and PASW
®
 18.0 software. Parametric and non-parametric statistical tests were 
used.  
Results 
1640 patients (1102 men) were involved in both studies. The average age was 66 years in the 
first study and 71 years in the second one. The frequency of prescribing of main groups of 
EBM therapy was 75 – 79 % of patients in both studies. The frequency of prescribing was 
higher (85 – 87 % of patients) in antiplatelet, anticoagulant or combined therapy. About 75 % 
of patients in MI secondary prevention used at least three out of four EBM drugs. Reduced 
prescription was recorded depending on patients’ age (p < 0.05) especially in all particular 
EBM drugs and their combinations in the second study as well as in beta-blockers and 
antiplatelet drugs in the first one. No relation to prescription of these groups of drugs 
depending upon patients’ gender was found. Low compensation rate of particular risk factors 
of cardiovascular diseases was found in the first study. Only about 10 % of patients after 
myocardial infarction had compensated their blood pressure and total cholesterol to target 
values. 
Conclusions 
Our results from both studies show that using EBM therapy after myocardial infarction in the 
Czech Republic is comparable to other advanced countries, though it is not still optimal 
similar to the level of compensation of cardiovascular diseases risk factors. It is necessary to 
focus on improving of the quality of care of these patients because there are a high percentage 
of patients who are not treated adequately. Professional medical societies of GPs and 
specialists should play their key roles. Pharmacists and clinical pharmacists should join them 
as well. Health insurance companies, whose big roles are still not alleged enough, should 
guarantee quality and accessible care for their clients. 
2. The analysis of attitudes, opinions and experience of general practitioners 
with generic drugs and generic substitution in the Czech Republic 
Aim 
The target was to obtain opinions, knowledge and experienced of general practitioners with 
generic drugs and generic substitution one year after the introduction of this system in the 
Czech Republic. 
Methods 
A 28-item questionnaire which was inspired by similar studies abroad and adjusted for the 
conditions in the Czech Republic was used for data collection. All general practitioners who 
took part in the 27
th
 National Conference SVL ČLS JEP and in the regional conferences of 
this professional community from November 2008 to March 2009 were addressed. Statistical 
analysis was carried out in PASW
®
 18 software. Statistical correlations were tested by 
selected parametric and non-parametric tests. 
Results 
263 filled questionnaires were given back (the returnability was 14.3 %). The average 
respondents’ age was 52.5 ± 13.7 years and 67.3 % were females. 37.6 % of respondents 
considered generic drugs to be bioequivalent to brand name drugs. 46 % of respondents 
believed that generic drugs are of lower quality than brand name drugs. Only 21.6 % of 
respondents looked at generic substitution positively. No respondent knew all legal rules of 
generic substitution implementation. The knowledge of legal rules and attitude towards 
generic substitution correlated with the respondents’ age. The younger respondents had a 
better knowledge of legal rules (p = 0.028) of generic substitution implementation and they 
had a more positive attitude to it as well (p = 0.024). About one fourth of respondents (23.2 
%) stated that in the previous month they had faced drug problems that had arisen because of 
generic substitution. In most cases the dose duplicity in using two drugs with the same active 
substance and the occurrence of adverse effects in substitution of one drug for another were 
mentioned. 
Conclusions 
On the one hand, generic substitution is an instrument that contributes to financial expenses 
savings for drugs; on the other hand it can bring some risks into patients’ pharmacotherapy. In 
our study we proved a relatively poor knowledge of general practitioners about the principle 
of the entry of generic drugs to the pharmaceutical market and about the conditions of generic 
substitution implementation. 
Some drug problems within the context of generic substitution implementation were recorded. 
Some measures that could contribute to the minimization of these risks of these drug-related 
problems were suggested. Labelling the covers of drugs by international non-proprietary 
name of active substance would especially belong to these measures as well as the measure of 
increasing reporting of drug problems arisen in connection with generic substitution. On the 
basis of these reports a list of interchangeable drugs would be created and updated. 
3. Risks and safety of self-medication by non-prescription drugs with content of 
non-steroidal anti-inflammatory drugs with the focus on ibuprofen 
Aim 
The aim of this part was to obtain and analyse data about the experience and knowledge of 
senior citizens with self-medication of pain with the help of non-prescription analgetics with 
the focus on the ibuprofen active substance. 
Methodology 
A cross-sectional study was carried out in retirement communities in Liberecky region and 
Central Bohemia region. A 19-item questionnaire was used for data collection that took place 
from April to August 2010. The direct interview with respondents was chosen as the main 
method. Statistical analysis was carried out in SPSS
®
 16.0 software. Statistical correlations 
were tested by selected parametric and non-parametric tests. 
Results 
9 retirement communities (out of 18 addressed) were involved in the study. 200 senior 
citizens were included (77 % females, average age 83 ± 7 years), which was 21.7 % of clients 
of these retirement communities. 64.3 % of respondents suffered from pain almost every day. 
The muscles and joints were the most common site of pain, followed by back and lower back 
pain. A large part of respondents used self-medication (45 %). Respondents preferred drugs 
with the content of ibuprofen (35.9 %) and paracetamol (30.0 %) in self-medication. The use 
of topical drugs containing non-steroidal analgetics was only minor (1.9 %). The best known 
effect of ibuprofen was the analgetic one (57.6 %) while only a small part of respondents 
knew the antipyretic (5.2 %) and antiphlogistic (7.2 %) effects. Younger and more educated 
respondents had better knowledge of ibuprofen indications (p < 0.05). Knowledge of adverse 
effects and interactions of ibuprofen were on a low level. 57.8 % of respondents replied that 
they had not known about the adverse effects of ibuprofen. 16 % of respondents thought that 
there were not any adverse effects of ibuprofen and only 9 % of them knew about serious 
adverse effects. Older respondents considered adverse effects of ibuprofen as less serious (p = 
0.017). Similarly the knowledge of interactions of ibuprofen was very low because 84 % of 
respondents did not know about any particular interactions. 
Conclusions 
Data from our study confirm results of few previous studies that the knowledge of OTC drugs 
is generally poor. Although most respondents suffered from pain almost daily and ibuprofen 
was most often used analgetics, the major part of respondents had not been aware of the fact 
that ibuprofen was connected with some drug-related problems (adverse effects, interactions). 
Senior citizens are a part of population which pharmaceutical care should focus on especially 
because of polymorbidity, polypharmacotherapy and the frequent use of OTC drugs. This part 
of population had better choose paracetamol and local formulated drugs NSAIDs. Pharmacists 
or pharmaceutical assistants should guarantee safe and effective self-medications and should 
try to minimize the occurrence of drug-related problems. 
 
